Is spleen volume reduction the primary treatment goal in myelofibrosis?

Sponsored by Novartis Pharmaceuticals Australia Pty Ltd

The goal for treatment in people with myelofibrosis should shift towards a greater emphasis on reduction in spleen volume, since this is likely to impact overall survival, according to medical oncologist Professor Srdan Verstovsek from the Department of Leukemia at The University of Texas MD Anderson Cancer Center, Houston, Texas. To this end, he says it’s ...

Already a member?

Login to keep reading.

© 2021 the limbic